SEC 13F Intelligence

Hood River Capital Management LLC / ARWR

Hood River Capital Management LLC’s Arrowhead Pharmaceuticals In Position

Does Hood River Capital Management LLC own Arrowhead Pharmaceuticals In (ARWR)? Yes1.06M shares worth $66M (+0.66% of its 13F portfolio) as of Q1 2026, up from 373.3K shares the prior filed quarter.

Position Value
$66M
Q1 2026
Shares
1.06M
% of Portfolio
+0.66%
Quarters Held
12
currently held

Position History ARWR

Reported value by quarter
Q2 ’20: $18MQ2 ’20Q3 ’20: $17MQ4 ’20: $30MQ4 ’20Q1 ’21: $24MQ2 ’21: $29MQ2 ’21Q3 ’21: $21MQ4 ’21: $22MQ4 ’21Q1 ’22: $16MQ2 ’22: $13MQ2 ’22Q3 ’22: $12MQ4 ’22: $15MQ4 ’22Q1 ’26: $66Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.06M$66M+0.66%
Q4 2022373.3K$15M+0.55%
Q3 2022371.6K$12M+0.47%
Q2 2022363.4K$13M+0.51%
Q1 2022345.1K$16M+0.53%
Q4 2021338.2K$22M+0.67%
Q3 2021338.7K$21M+0.65%
Q2 2021352.1K$29M+0.87%
Q1 2021357.1K$24M+0.76%
Q4 2020393.3K$30M+1.00%
Q3 2020385.3K$17M+0.72%
Q2 2020424.1K$18M+0.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hood River Capital Management LLC’s full portfolio or all institutional holders of ARWR.